Author: Bhatia, Rohit; Srivastava, M. V. Padma; Khurana, Dheeraj; Pandit, Lekha; Mathew, Thomas; Gupta, Salil; Netravathi, M; Nair, Sruthi S.; Singh, Gagandeep; Singhal, Bhim S.
Title: Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology Cord-id: n4w862z1 Document date: 2020_4_13
ID: n4w862z1
Snippet: Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during
Document: Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and acute treatment: 1, 2
- action mechanism and acute treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- active infection and acute relapse: 1, 2
- active infection and acute treatment: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date